Argos Therapeutics to Present at 21st Annual Future Leaders in the Biotech Industry Conference
March 21, 2014 12:30 ET
|
Argos Therapeutics, Inc.
DURHAM, N.C., March 21, 2014 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq:ARGS), a biopharmaceutical company focused on the development and commercialization of personalized immunotherapies...
Standard Exercise - Norwegian Stock 10/14
March 21, 2014 12:20 ET
|
Derivatives
See attached document for series that are in-the-money and will be exercised.
For further information concerning this exchange notice please contact Nordic Operations,
telephone +46 8...
Closing Values Confirmed for Nordic and International market
March 21, 2014 12:19 ET
|
Nasdaq Commodities
Closing Values Confirmed for Nordic and International market
NOTE: From the 7th of April 2014, NASDAQ OMX will no longer send this operational message. Information is available in Genium INET...
Host Analytics Positioned in the 'Visionaries' Quadrant of the 2014 Magic Quadrant for Corporate Performance Management Suites
March 21, 2014 12:17 ET
|
Host Analytics
REDWOOD CITY, CA--(Marketwired - Mar 21, 2014) - Host Analytics, the leader in cloud-based Enterprise Performance Management (EPM), today announced that it has been positioned by Gartner, Inc. in...
OMXC20CAP Expiration Value 20/14
March 21, 2014 12:16 ET
|
Derivatives
The Index Calculator has established the definitive value for OMXC20CAP futures and options expiring in March 2014 to 732,94
For further information...
Horn Petroleum Update
March 21, 2014 12:12 ET
|
Horn Petroleum Corporation
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 21, 2014) - Horn Petroleum Corporation ("Horn" or the "Company") (TSX VENTURE:HRN) reports that in response to recent market activity and...
Sycamore Entertainment Group Inc. Corporate Update
March 21, 2014 12:03 ET
|
Sycamore Entertainment
Hollywood, March 21, 2014 (GLOBE NEWSWIRE) --
Sycamore
Entertainment Group, Inc.(SEGI), a leading
innovator in hybrid film distribution, is pleased to provide this
corporate...
IPSOS: MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS
March 21, 2014 12:00 ET
|
IPSOS
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
...
NASDAQ Welcomes Versartis, Inc. (NASDAQ:VSAR) to The NASDAQ Stock Market
March 21, 2014 12:00 ET
|
Nasdaq, Inc.
NEW YORK, March 21, 2014 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced that trading of Versartis, Inc. (Nasdaq:VSAR), a biopharmaceutical company developing long-acting...
- 03 juin 2024 07h30 HE Abcourt recoupe 91,8 g/t Au sur 0,5m à la mine Géant Dormant
- 02 juin 2024 10h00 HE Nanobiotix annonce de nouvelles données montrant un contrôle de la maladie et une réponse tumorale chez des patients traités avec NBTXR3 activé par radiothérapie suivi d’un anti-PD-1, comme traitement de deuxième intention ou plus, dans le cancer de la tête et du cou récurrent ou métastatique, naïf ou résistant aux anti-PD-1